In world first, Cuba starts Covid jabs for toddlers | Inquirer News

In world first, Cuba starts Covid jabs for toddlers

/ 08:36 AM September 07, 2021

CUBA SOBERANA

In this file photo taken on March 31, 2021, nurse Xiomara Rodriguez shows a vial of the Cuban Soberana 2 vaccine candidate to be administered to a volunteer during its trial Phase III in Havana. – Cuba will begin immunising its population against the coronavirus during the first half of May, mainly in Havana and the provinces of Santiago de Cuba (east) and Matanzas (centre), with two vaccine candidates developed on the island, officials said on May 7, 2021. (Photo by Joaquin Hernandez / AFP)

HAVANA, Cuba – Cuba on Monday became the first country in the world to vaccinate children from the age of two against COVID-19, using home-grown jabs not recognized by the World Health Organization.

The communist island of 11.2 million people aims to inoculate all its children before reopening schools that have been closed for the most part since March 2020.

Article continues after this advertisement

The new school year started on Monday, but from home via television programs, as most Cuban homes do not have internet access.

FEATURED STORIES

Having completed clinical trials on minors with its Abdala and Soberana vaccines, Cuba kicked off its inoculation campaign for children on Friday, starting with those 12 and older.

On Monday, it started distributing jabs in the 2-11 age group in the central province of Cienfuegos.

Article continues after this advertisement

Several other countries in the world are vaccinating children from the age of 12, and some are conducting trials in younger kids.

Article continues after this advertisement

Countries such as China, the United Arab Emirates and Venezuela have announced they plan to vaccinate younger children, but Cuba is the first to do so.

Article continues after this advertisement

Chile on Monday approved the Chinese Sinovac vaccines for children between six and 12.

The Cuban vaccines, the first developed in Latin America, have not undergone international, scientific peer review.

Article continues after this advertisement

They are based on recombinant protein technology — the same used by the United States’ Novavax and France’s Sanofi jabs also awaiting WHO approval.

Unlike many other shots in use, recombinant vaccines do not require extreme refrigeration.

The majority of schools in Cuba have been closed since March 2020, reopening for a few weeks at the end of last year before closing again in January.

The government has announced schools will reopen gradually, in October and November, but only after all children have been vaccinated.

UN agency UNICEF has called for schools worldwide to reopen as soon as possible, as “the long-term costs of closures are too high and hard to justify.”

Cuba has seen an explosion in coronavirus infections in recent months, putting pressure on its health system.

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

Of the 5,700 coronavirus deaths recorded since the outbreak started, nearly half were in the last month alone, as were almost a third of all reported cases.

gsg

For more news about the novel coronavirus click here.
What you need to know about Coronavirus.
For more information on COVID-19, call the DOH Hotline: (02) 86517800 local 1149/1150.

The Inquirer Foundation supports our healthcare frontliners and is still accepting cash donations to be deposited at Banco de Oro (BDO) current account #007960018860 or donate through PayMaya using this link.

TAGS: COVID-19, Cuba, Toddler, vaccine

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

© Copyright 1997-2024 INQUIRER.net | All Rights Reserved

This is an information message

We use cookies to enhance your experience. By continuing, you agree to our use of cookies. Learn more here.